RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes

Severe coronavirus disease 2019 (COVID-19) is characterized by symptoms of lymphopenia and multiorgan damage, but the underlying mechanisms remain unclear. To explore the function of N6-methyladenosine (m6A) modifications in COVID-19, we performed microarray analyses to comprehensively characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Yuting, Zhang, Qiong, Wang, Kaihang, Zhang, Xujun, Yang, Rongwei, Bi, Kefan, Chen, Wenbiao, Diao, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298984/
https://www.ncbi.nlm.nih.gov/pubmed/34301919
http://dx.doi.org/10.1038/s41419-021-04012-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298984/
https://www.ncbi.nlm.nih.gov/pubmed/34301919
http://dx.doi.org/10.1038/s41419-021-04012-z

Ejemplares similares